vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $35.3M, roughly 1.3× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -19.9%, a 63.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 24.2%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 17.5%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
ABCL vs UNTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $35.3M |
| Net Profit | $-8.9M | $15.5M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 55.8% |
| Net Margin | -19.9% | 43.9% |
| Revenue YoY | 788.4% | 24.2% |
| Net Profit YoY | 73.9% | 34.5% |
| EPS (diluted) | $-0.03 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $35.3M | ||
| Q3 25 | $9.0M | $32.8M | ||
| Q2 25 | $17.1M | $34.4M | ||
| Q1 25 | $4.2M | $29.4M | ||
| Q4 24 | $5.0M | $28.4M | ||
| Q3 24 | $6.5M | $27.7M | ||
| Q2 24 | $7.3M | $25.5M | ||
| Q1 24 | $10.0M | $25.6M |
| Q4 25 | $-8.9M | $15.5M | ||
| Q3 25 | $-57.1M | $14.4M | ||
| Q2 25 | $-34.7M | $16.5M | ||
| Q1 25 | $-45.6M | $11.6M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | $-51.1M | $10.9M | ||
| Q2 24 | $-36.9M | $9.5M | ||
| Q1 24 | $-40.6M | $9.6M |
| Q4 25 | -63.7% | 55.8% | ||
| Q3 25 | -851.8% | 57.5% | ||
| Q2 25 | -290.2% | 62.6% | ||
| Q1 25 | -1479.6% | 52.6% | ||
| Q4 24 | — | 51.0% | ||
| Q3 24 | -1439.4% | 52.7% | ||
| Q2 24 | -1276.2% | 49.3% | ||
| Q1 24 | -551.5% | 50.0% |
| Q4 25 | -19.9% | 43.9% | ||
| Q3 25 | -637.8% | 43.8% | ||
| Q2 25 | -203.3% | 48.0% | ||
| Q1 25 | -1077.2% | 39.5% | ||
| Q4 24 | — | 40.5% | ||
| Q3 24 | -785.4% | 39.4% | ||
| Q2 24 | -504.3% | 37.1% | ||
| Q1 24 | -408.0% | 37.5% |
| Q4 25 | $-0.03 | $1.52 | ||
| Q3 25 | $-0.19 | $1.41 | ||
| Q2 25 | $-0.12 | $1.61 | ||
| Q1 25 | $-0.15 | $1.13 | ||
| Q4 24 | — | $1.13 | ||
| Q3 24 | $-0.17 | $1.07 | ||
| Q2 24 | $-0.13 | $0.92 | ||
| Q1 24 | $-0.14 | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $345.6M |
| Total Assets | $1.4B | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | $345.6M | ||
| Q3 25 | $964.0M | $334.0M | ||
| Q2 25 | $1.0B | $319.8M | ||
| Q1 25 | $1.0B | $306.1M | ||
| Q4 24 | $1.1B | $295.6M | ||
| Q3 24 | $1.1B | $284.3M | ||
| Q2 24 | $1.1B | $273.4M | ||
| Q1 24 | $1.1B | $266.8M |
| Q4 25 | $1.4B | $3.0B | ||
| Q3 25 | $1.4B | $2.9B | ||
| Q2 25 | $1.4B | $2.9B | ||
| Q1 25 | $1.3B | $2.8B | ||
| Q4 24 | $1.4B | $2.7B | ||
| Q3 24 | $1.4B | $2.6B | ||
| Q2 24 | $1.4B | $2.6B | ||
| Q1 24 | $1.5B | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $44.9M |
| Free Cash FlowOCF − Capex | $-44.6M | $44.3M |
| FCF MarginFCF / Revenue | -99.4% | 125.7% |
| Capex IntensityCapex / Revenue | 21.9% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $44.9M | ||
| Q3 25 | $-52.6M | $45.5M | ||
| Q2 25 | $-32.4M | $-25.3M | ||
| Q1 25 | $-11.6M | $17.9M | ||
| Q4 24 | $-108.6M | $48.0M | ||
| Q3 24 | $-28.9M | $17.7M | ||
| Q2 24 | $-30.0M | $-8.4M | ||
| Q1 24 | $-41.7M | $15.8M |
| Q4 25 | $-44.6M | $44.3M | ||
| Q3 25 | $-61.5M | $45.3M | ||
| Q2 25 | $-45.8M | $-25.5M | ||
| Q1 25 | $-22.2M | $17.6M | ||
| Q4 24 | $-187.0M | $47.3M | ||
| Q3 24 | $-47.4M | $17.5M | ||
| Q2 24 | $-50.1M | $-8.6M | ||
| Q1 24 | $-65.8M | $15.7M |
| Q4 25 | -99.4% | 125.7% | ||
| Q3 25 | -687.0% | 138.1% | ||
| Q2 25 | -267.9% | -74.2% | ||
| Q1 25 | -524.0% | 59.9% | ||
| Q4 24 | -3702.8% | 166.5% | ||
| Q3 24 | -728.4% | 63.3% | ||
| Q2 24 | -683.8% | -33.7% | ||
| Q1 24 | -661.5% | 61.4% |
| Q4 25 | 21.9% | 1.6% | ||
| Q3 25 | 99.7% | 0.7% | ||
| Q2 25 | 78.2% | 0.5% | ||
| Q1 25 | 251.1% | 1.0% | ||
| Q4 24 | 1552.7% | 2.4% | ||
| Q3 24 | 284.6% | 0.5% | ||
| Q2 24 | 274.6% | 0.5% | ||
| Q1 24 | 242.5% | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
